Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia

Ole Köhler-Forsberg^{1

2

3}, Norbert Müller⁴, Belinda R Lennox⁵

Affiliations

¹ Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
² Department for Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
³ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁴ Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
⁵ Department of Psychiatry, University of Oxford, Oxford, United Kingdom.

Editorial

Ole Köhler-Forsberg et al. Front Psychiatry. 2020.

. 2020 Oct 22:11:603296.

doi: 10.3389/fpsyt.2020.603296. eCollection 2020.

Ole Köhler-Forsberg^{1

2

3}, Norbert Müller⁴, Belinda R Lennox⁵

¹ Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
² Department for Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
³ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁴ Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
⁵ Department of Psychiatry, University of Oxford, Oxford, United Kingdom.

No abstract available

Keywords: anti-inflammatory; autoimmune psychosis; immunopsychiatry; inflammation; psychose; schizophrenia.

Comment on

Editorial on the Research Topic The Role of Inflammation in the Etiology and Treatment of Schizophrenia

1. Orlovska-Waast S, Kohler-Forsberg O, Brix SW, Nordentoft M, Kondziella D, Krogh J, et al. . Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Mol Psychiatry. (2019) 24:869–87. 10.1038/s41380-018-0220-4 - DOI - PMC - PubMed
1. Yuan N, Chen Y, Xia Y, Dai J, Liu C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry. (2019) 9:233. 10.1038/s41398-019-0570-y - DOI - PMC - PubMed
1. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. . Schizophrenia risk from complex variation of complement component 4. Nature. (2016) 530:177–83. 10.1038/nature16549 - DOI - PMC - PubMed
1. Kohler O, Petersen L, Mors O, Mortensen PB, Yolken RH, Gasse C, et al. . Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr Scand. (2017) 135:97–105. 10.1111/acps.12671 - DOI - PubMed
1. Nitta M, Kishimoto T, Müller N, Weiser M, Davidson M, Kane JM, et al. . Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull. (2013) 39:1230–41. 10.1093/schbul/sbt070 - DOI - PMC - PubMed